Rigel Pharmaceuticals Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
San Francisco, CA Indonesia
Total Funding:N/A
Industry:Biotech
Founded:1996
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Rigel Pharmaceuticals's estimated annual revenue is currently $46.8M per year.
  • Rigel Pharmaceuticals received $71.8M in venture funding in April 2018.
  • Rigel Pharmaceuticals's estimated revenue per employee is $155,000

Employee Data

  • Rigel Pharmaceuticals has 302 Employees.
  • Rigel Pharmaceuticals grew their employee count by 4% last year.
  • Rigel Pharmaceuticals currently has 4 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$7M4510%N/A-N/A
#2
N/A205N/AN/A-N/A
#3
$46.8M3024%N/A-N/A
#4
$22.3M144N/AN/A-N/A
#5
$44.3M286N/AN/A-N/A
#6
$101.2M65346%N/A-N/A
#7
$18.6M120N/AN/A-N/A
#8
$23.3M150N/AN/A-N/A
#9
$33.3M2153%N/A-N/A
#10
$28.7M1858%N/A-N/A
Missing a competitor? Contribute!?
Submit

Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

302

Number of Employees

$46.8M

Revenue (est)

4

Current Jobs

4%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Rigel Pharmaceuticals News

09/03/2019 - Tempting figures:: Rigel Pharmaceuticals, Inc., (NASDAQ: RIGL)

Each buying and selling session display one-of-a-kind actions and patterns about Rigel Pharmaceuticals, Inc. RIGL), Biotechnology stock.

09/08/2019 - Identifying The Sweet Spot For SINA Corporation (SINA), Rigel Pharmaceuticals (RIGL)

With the previous 100-day trading volume average of 1.32 million shares, Rigel Pharmaceuticals (RIGL) recorded a trading volume of 1.56 ...

09/03/2019 - Acadian Asset Management LLC Increases Stock Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Acadian Asset Management LLC boosted its position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) by 548.3% in the second ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$54.7M304N/AN/A-N/A
#2
$83.7M31012%$541M-N/A
#3
$47.3M3264%N/A-N/A
#4
$33.6M32633%$114.4M-N/A
#5
N/A344N/AN/A-N/A

Rigel Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2002-01-18$31.5MPublic OfferingArticle
2003-05-01$46.0MLead Investor: MPM CArticle
2003-06-30$46.0MCommon StockMPM CapitalArticle
2003-08-04$9.3MRights OfferingArticle
2009-09-19$108.3MUndisclosedCredit Suisse Securities (USA)Article
2011-05-26$UndisclosedUndisclosedJefferies & Company Inc, J P Morgan Securities LLCArticle
2012-10-04$130.0MUndisclosedJefferies & Company Inc, J P Morgan Securities LLCArticle
2017-02-01$40.0MUndisclosedJefferies LLCArticle
2017-10-04$46.0MUndisclosedJefferies LLCArticle
2017-10-05$69.7MUndisclosedBMO Capital Markets CorpArticle
2018-04-20$71.8MUndisclosedJefferies LLCArticle

Rigel Pharmaceuticals Executive Hires

DateNameTitleReference
2002-10-31Susan ScherVP Strategic RelationsArticle
2003-10-08Robin CooperSVP Pharmaceutical SciencesArticle
2004-06-17Raul RodriguezCOOArticle
2006-06-07Ryan D. MaynardVP Finance/CFOArticle
2008-02-27Daniel B. MagilavyVP Clinical ResearchArticle
2010-06-02Raul RodriguezPresident/COOArticle
2014-11-25Raul RodriguezPresident/COO/CEOArticle
2016-03-09Anne-Marie Duliegechief medical officerArticle
2016-09-16Eldon C. MayerEVP/Chief commercial officerArticle
2016-10-10Esteban MasudaSVP ResearchArticle
2017-12-18Nelson Cabatuaninterim principal accounting officerArticle
2018-05-31Dean SchornoEVP/CFOArticle

Rigel Pharmaceuticals Staff Cuts

DateNumber of EmployeesLocationReference
2009-02-0420 % of StaffArticle
2016-09-1646Article